Combined brain-derived neurotrophic factor and neurotrophin-3 treatment is preferred over either one separately in the preservation of the auditory nerve in deafened guinea pigs.

导出 LinkOut

翻译打印收藏纠错

第一作者： Henk A,Vink

第一单位： Department of Otorhinolaryngology and Head & Neck Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.

作者： Henk A,Vink ^[1] ; Dyan,Ramekers ^[2] ; Hans G X M,Thomeer ^[1] ; Huib,Versnel ^[2]

作者单位： Department of Otorhinolaryngology and Head & Neck Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands. ^[1] UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands. ^[2]

关键词 cochlea cochlear implant eCAP hearing loss neurodegeneration neuroprotection neurotrophin

DOI 10.3389/fnmol.2022.935111

PMID 36226314

发布时间 2022-10-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in molecular neuroscience

2022年15卷

935111页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Combined brain-derived neurotrophic factor and neurotrophin-3 treatment is preferred over either one separately in the preservation of the auditory nerve in deafened guinea pigs.

Frontiers in molecular neuroscience

相似文献

Frontiers in molecular neuroscience

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Combined brain-derived neurotrophic factor and neurotrophin-3 treatment is preferred over either one separately in the preservation of the auditory nerve in deafened guinea pigs.

Frontiers in molecular neuroscience

相似文献

Frontiers in molecular neuroscience

相关期刊

检索历史清除